OFIX Orthofix Medical Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: OFIX

Price (delayed)

$6.95

Market cap

$283.28M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$1.11

Enterprise value

$431.21M

Sign up for free to view scoring metrics ?
Relative Growth: Rel. Growth:
Relative Strength: Rel. Strength:
Relative Valuation: Rel. Valuation:
Relative Profitability: Rel. Profitability: 44

Orthofix is a global medical technology company headquartered in Lewisville, Texas. By providing medical technologies that heal musculoskeletal pathologies, Orthofix delivers exceptional experiences and life-changing solutions to patients around the ...

Highlights
The EPS has soared by 63% YoY and by 27% from the previous quarter
The net income has soared by 62% YoY and by 27% from the previous quarter
Orthofix Medical's debt has increased by 34% YoY
The equity has contracted by 2.9% YoY
Sector: Healthcare
Industry: Medical Devices
Website: http://www.orthofix.com
Peers: ATEC SYK GMED

Key stats

What are the main financial stats of OFIX

OFIX stock price

How has the Orthofix Medical stock price performed over time
Intraday
-3.2%
1 week
-22.09%
1 month
-25.11%
1 year
-54.58%
YTD
-54.16%
QTD
-26.14%

Financial performance

How have Orthofix Medical's revenue and profit performed over time
Revenue
$835.41M
Gross profit
$592.14M
Operating income
-$20.53M
Net income
-$45M
Gross margin
70.9%
Net margin
-5.4%
The company's operating margin has surged by 78% YoY and by 47% QoQ
The company's operating income has surged by 78% YoY and by 48% QoQ
Orthofix Medical's net margin has soared by 63% YoY and by 27% from the previous quarter
The net income has soared by 62% YoY and by 27% from the previous quarter

Price vs fundamentals

How does OFIX's price correlate with its fundamentals

Growth

What is Orthofix Medical's growth rate over time

Valuation

What is Orthofix Medical stock price valuation
P/E
N/A
P/B
0.66
P/S
0.34
EV/EBIT
N/A
EV/EBITDA
13.59
EV/Sales
0.52
The EPS has soared by 63% YoY and by 27% from the previous quarter
The stock's price to book (P/B) is 43% less than its 5-year quarterly average of 1.2 and 32% less than its last 4 quarters average of 1.0
The equity has contracted by 2.9% YoY
The price to sales (P/S) is 56% lower than the 5-year quarterly average of 0.8 and 42% lower than the last 4 quarters average of 0.6
The revenue is up by 2.1% year-on-year

Efficiency

How efficient is Orthofix Medical business performance
The ROIC has soared by 79% YoY and by 49% from the previous quarter
The ROS has soared by 77% YoY and by 47% from the previous quarter
OFIX's return on assets has surged by 63% year-on-year and by 28% since the previous quarter
OFIX's ROE has soared by 60% YoY and by 27% QoQ

Dividends

What is OFIX's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for OFIX.

Financial health

How did Orthofix Medical financials performed over time
The total assets is 101% greater than the total liabilities
Orthofix Medical's quick ratio has increased by 28% YoY and by 3.3% QoQ
The current ratio has grown by 26% YoY and by 10% from the previous quarter
Orthofix Medical's debt is 45% less than its equity
OFIX's debt to equity is up by 38% YoY
Orthofix Medical's debt has increased by 34% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.